Fortress Biotech, Inc. 4
4 · Fortress Biotech, Inc. · Filed Jan 24, 2017
Insider Transaction Report
Form 4
Klein Dov
Director
Transactions
- Award
Deferred Restricted Stock Units
2017-01-01+26,666→ 39,999 totalExercise: $0.00→ Common Stock (26,666 underlying) - Award
Common Stock, par value $0.001
2017-01-01+100,000→ 241,667 total - Disposition to Issuer
Common Stock, par value $0.001
2017-01-01−26,666→ 215,001 total
Holdings
- 1,800(indirect: By Spouse)
Common Stock, par value $0.001
Footnotes (3)
- [F1]One-third of the shares will vest on each of January 1, 2018, 2019 and 2020, and subject to continued service on the board of directors.
- [F2]The Reporting Person was granted 100,000 shares of restricted common stock of the Issuer on January 1, 2016 for his service on the Issuer's Board of Directors. The shares vest one-third annually beginning on January 1, 2017. The Reporting Person deferred the receipt of 80% of the vested shares and, on January 1, 2017, received instead 26,666 shares of deferred restricted stock units pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). As a result, the Reporting Person is reporting the disposition of 26,666 shares of Issuer common stock in exchange for an equal number of deferred restricted stock units.
- [F3]Each deferred restricted stock unit will be settled in one share of the Issuer's common stock at the time and in the matter set forth in the Plan.